Immediate Impact
68 standout
Citing Papers
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
2024 Standout
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Works of Willem Grootjans being referenced
PET in the management of locally advanced and metastatic NSCLC
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Willem Grootjans | 317 | 191 | 57 | 86 | 37 | 432 | |
| Gurvan Dissaux | 294 | 235 | 99 | 70 | 33 | 420 | |
| Khaled Bousabarah | 294 | 139 | 39 | 69 | 29 | 460 | |
| Giacomo Feliciani | 328 | 176 | 55 | 120 | 31 | 428 | |
| Thomas Weißmann | 191 | 137 | 79 | 40 | 40 | 416 | |
| O. Miranda | 371 | 94 | 31 | 90 | 21 | 450 | |
| David Bourhis | 401 | 142 | 60 | 114 | 56 | 508 | |
| Stéphanie Pitre-Champagnat | 248 | 105 | 56 | 152 | 26 | 424 | |
| Urban Simončič | 236 | 135 | 27 | 42 | 32 | 373 | |
| Michael C. Tjong | 224 | 224 | 123 | 64 | 36 | 456 | |
| Aslı Okur | 201 | 190 | 89 | 88 | 18 | 450 |
All Works
Login with ORCID to disown or claim papers
Loading papers...